DNA methylation in lymphoma: An opportunity?

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Epigenetic mechanisms, including DNA methylation, play an important role in not only the development and maturation of normal cells, but also the development and progression of malignant cells.1 In this edition of Blood, Arribas et al show that DNA methylation profiling identifies 2 subtypes of splenic marginal zone lymphoma with different clinical and genetic features.2 These findings provide an opportunity to better understand the biology of marginal zone lymphoma and optimize therapy by using demethylating agents to reverse the high-methylation phenotype and thereby target malignant B cells.

Original languageEnglish (US)
Pages (from-to)1848-1849
Number of pages2
JournalBlood
Volume125
Issue number12
DOIs
StatePublished - Mar 19 2015

Fingerprint

DNA Methylation
Lymphoma
Methylation
DNA Fingerprinting
Epigenomics
Blood
B-Lymphocytes
Cells
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

DNA methylation in lymphoma : An opportunity? / Ansell, Stephen Maxted.

In: Blood, Vol. 125, No. 12, 19.03.2015, p. 1848-1849.

Research output: Contribution to journalArticle

Ansell, Stephen Maxted. / DNA methylation in lymphoma : An opportunity?. In: Blood. 2015 ; Vol. 125, No. 12. pp. 1848-1849.
@article{74028498494a44cd929642c86329d620,
title = "DNA methylation in lymphoma: An opportunity?",
abstract = "Epigenetic mechanisms, including DNA methylation, play an important role in not only the development and maturation of normal cells, but also the development and progression of malignant cells.1 In this edition of Blood, Arribas et al show that DNA methylation profiling identifies 2 subtypes of splenic marginal zone lymphoma with different clinical and genetic features.2 These findings provide an opportunity to better understand the biology of marginal zone lymphoma and optimize therapy by using demethylating agents to reverse the high-methylation phenotype and thereby target malignant B cells.",
author = "Ansell, {Stephen Maxted}",
year = "2015",
month = "3",
day = "19",
doi = "10.1182/blood-2015-02-625293",
language = "English (US)",
volume = "125",
pages = "1848--1849",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - DNA methylation in lymphoma

T2 - An opportunity?

AU - Ansell, Stephen Maxted

PY - 2015/3/19

Y1 - 2015/3/19

N2 - Epigenetic mechanisms, including DNA methylation, play an important role in not only the development and maturation of normal cells, but also the development and progression of malignant cells.1 In this edition of Blood, Arribas et al show that DNA methylation profiling identifies 2 subtypes of splenic marginal zone lymphoma with different clinical and genetic features.2 These findings provide an opportunity to better understand the biology of marginal zone lymphoma and optimize therapy by using demethylating agents to reverse the high-methylation phenotype and thereby target malignant B cells.

AB - Epigenetic mechanisms, including DNA methylation, play an important role in not only the development and maturation of normal cells, but also the development and progression of malignant cells.1 In this edition of Blood, Arribas et al show that DNA methylation profiling identifies 2 subtypes of splenic marginal zone lymphoma with different clinical and genetic features.2 These findings provide an opportunity to better understand the biology of marginal zone lymphoma and optimize therapy by using demethylating agents to reverse the high-methylation phenotype and thereby target malignant B cells.

UR - http://www.scopus.com/inward/record.url?scp=84925379436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925379436&partnerID=8YFLogxK

U2 - 10.1182/blood-2015-02-625293

DO - 10.1182/blood-2015-02-625293

M3 - Article

C2 - 25792729

AN - SCOPUS:84925379436

VL - 125

SP - 1848

EP - 1849

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -